FDA clears IND application for cancer therapeutic IMT-009
9 days ago - By Healio
FDA cleared an investigational new drug application for IMT-009, a fully human monoclonal antibody that combats inhibitory T-cell target CD161, according to a company press release.
The IND clearance applies to patients who are refractory to standard-of-care therapy, or ineligible for or refused another existing treatment option.
The clearance of IMT-009 indicates the continuation of recent developments of cell therapy in cancer treatment.
“We are thrilled to advance IMT-009 to the clinic as we believe it represents a new wave of immuno-oncology agents with
Read more ...
The headlines of Master Doctor
AFL 2022 trade period LIVE updates: McKay sticks with Blues, Horne-Francis...
The AFL's silly season kicks off today. Follow live for all the news and analysis as trade period begins and player movement gets under way in earnest.
Identifying changes in topography key for cross-linking after PK, RK
CHICAGO - Regular topography, preferably performed annually after keratorefractive or penetrating keratoplasty surgery, is ideal for detecting ectasia, according to a...
VIDEO: ICL an option for customization of refractive surgery
CHICAGO - In this Healio Video Perspective from the AAO meeting, Deepinder Dhaliwal, MD, discusses corneal and lens-based solutions for refractive surgeons to consider...
Australia set for downpour this week
A week of wet weather is set to sweep across Australia.
Fishing contest rocked after weights found in winning catches
Video captured the moment - “We got weights in fish!” - that scandalised the lucrative Cleveland fishing contest.
Panthers' total football makes them kings of the jungle
Penrith destroyed Parramatta by winning pretty with speed and finesse one moment, while triumphing ugly with power and toughness the next.
Lockyer says Panthers can win threepeat
League legend Darren Lockyer says the Panthers have the ability to win three straight premierships.
Durvalumab-CRT Pairing Disappoints in Locally Advanced Cervical Cancer
NEW YORK - An immunotherapy-chemoradiotherapy combination did not boost progression-free survival in untreated, locally advanced cervical cancer, according to CALLA trial...
Kennett responds to Hawks allegations
Hawthorn president Jeff Kennett responds to shocking allegations aimed at the Hawks by First Nations players.
Rethinking Canberra: Atmospherics are right for a democratic spring
‘Reset' has become the most voguish word in Australian politics, but it fails to adequately capture how this moment is pregnant with possibility.